light-chain enhancer of activated B cells; OCA, obeticholic acid; TGR5, Takeda G protein-coupled receptor 5 (aka G protein-coupled bile acid receptor-1, Gpbar-1).
Introduction
report that activation of FXR antagonizes NF-κB in the hepatic inflammatory response and regulates intestinal innate immunity, and improves nonalcoholic fatty liver disease (6) (7) (8) (9) . Activation of TGR5 has been shown to inhibit atherosclerosis by reducing macrophage inflammation (10) and protect intestinal barrier function in mouse models of inflammatory bowel diseases (11) .
TGR5 is widely expressed in the gallbladder epithelium, ileum and colon. In the liver, TGR5 is expressed in Kupffer cells and sinusoidal endothelial cells, but not in hepatocytes (12) . Activation of TGR5 induces cAMP and stimulates glucagon-like peptide-1 (GLP-1) secretion from intestinal enteroendocrine L cells, which induces insulin secretion from β cells (13) . It has been reported that bile acids activate the TGR5-cAMP pathway to inhibit LPS-induced cytokine production in Kupffer cells, and suggested that TGR5 in Kupffer may play a protective role against excessive cytokine production and liver injury in obstructive cholestasis (14) , consistent with the finding that
Tgr5
-/-mice have more severe liver necrosis and inflammation compared to wild type mice (15) .
On the contrary, several recent studies show that TGR5 induces cytokine production in Kupffer cells (16) and enhances LPS-induced inflammatory response in a human monocyte cell line (17) .
Thus, the role of TGR5 signaling in hepatic inflammation is controversial and requires further study.
Currently, it is thought that progression from simple steatosis to nonalcoholic steatohepatitis (NASH) involves "multiple hits" such as endoplasmic reticulum stress, inflammatory cytokines, innate immunity and gut microbiota and epigenetic factors (18) (19) (20) (21) . Increasing evidence shows that dietary cholesterol increases oxidative stress and exacerbates high fat-high cholesterol dietinduced hepatic steatosis and inflammation (22) . Accumulation of free cholesterol in stellate cells and Kupffer cells aggravates liver fibrosis in mice (23) (24) (25) . Our previous study reported that transgenic overexpression of CYP7A1 in the liver prevents high-fat-high cholesterol diet-induced obesity and decreases inflammation in mice (26) . CYP7A1 plays a key role in regulation of hepatic cholesterol homeostasis by converting excess cholesterol to bile acids, which facilitate biliary cholesterol secretion. The aims of this study are to investigate the roles and mechanisms of by guest, on August 15, 2017 www.jlr.org
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CYP7A1 and bile acid-activated receptors in anti-inflammation and fibrosis in the liver. Our data show that increasing bile acid synthesis by overexpression of CYP7A1 ameliorates hepatic inflammation through activation of FXR but not TGR5. On the other hand, lack of Cyp7a1 aggravated MCD diet-induced liver fibrosis through accumulation of free cholesterol in hepatocytes. Our study suggests that CYP7A1 plays a critical role in control of hepatic inflammation and fibrosis by maintaining bile acid and cholesterol homeostasis.
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For the luciferase reporter assays, HepG2 cells were plated in 24-well plates and transiently co-transfected with the pNL3.2-NF-κB-RE reporter plasmids, β-gal expressing plasmid (for normalization of transfection efficiency) and pcDNA3-hFXR (as indicated) using TransFast™
Transfection Reagent (Promega, Madison, WI). After 48 h, transfected HepG2 cells were treated with TNF-α for 6 h or transfected with pCMV4-p65 plasmid for 24 h to stimulate NF-κB reporter activity, and FXR agonists GW4064 (1 µM, Sigma-Aldrich, St. Louis, MO) or obeticholic acid (OCA, 10 µM, Intercept Pharmaceuticals, Inc. New York, NY) was added to test their effect on reporter activity. Luciferase assays were performed and luciferase activity was normalized to β-gal activity as described previously (28) .
Chromatin Immunoprecipitation (ChIP) Assay
ChIP assays were performed with a ChIP assay kit (Millipore, Bedford, MA) according to the manufacturer's instructions. Briefly, liver tissues were homogenized and lysates were crosslinked in 1% formaldehyde and sonicated to break the DNA into 0. College of Medicine, Huston, TX) as described previously (27) .
ELISA Assay of proinflammatory cytokines
After LPS injection for 6 h, blood was collected from mice and centrifuged at 3,000 g for 10 min. The levels of IL-1β, IL-6 and TNF-α in the serum were measured using ELISA kits (Qiagen, Valencia, CA) according to the manufacturer's instructions.
Mammalian two-hybrid assay
For mammalian two-hybrid assays, HepG2 cells were co-transfected with luciferase reporter plasmid pG5luc, and Gal4-fusion protein plasmids and VP-16-p65 plasmids for 48 h.
Luciferase reporter activity was determined by dual luciferase reporter assay system (Promega, Madison, WI) according to the manufacturer's instructions. GAL4-FXR-FULL, GAL4-FXR-LBD, GAL4-FXR-DBD, GAL4-FXR-HINGE plasmids were generous gifts from Dr. Frederick J. Suchy (University of Colorado Health Sciences Center, Aurora, CO).
Histochemical and Immunohistochemical Staining
Liver tissues from mice were fixed in 10% formalin and embedded in paraffin. Tissue sections were then subjected to hematoxylin and eosin (H&E). For F4/80 (#6640, ABCAM) and α-SMA (#5694, ABCAM) immunohistochemistry (IHC), livers were fixed with paraformaldehyde and stained by using an avidin-biotin complex staining kit (Santa Cruz biotechnology, Santa Cruz, CA) according to the manufacturer's instructions. The images were visualized by microscopy (IX73, Olympus, Japan). 
Filipin staining of free cholesterol
Liver sections were fixed with 4% paraformaldehyde (fresh) for 1 h and stained with 0.05 mg/ml Filipin working solution for 2 h at room temperature. The images were visualized by fluorescence microscopy using a UV filter set (340-380nm excitation, 430nm emission).
Hepatic hydroxyproline assay
Livers were homogenized in water and hydrolyzed in concentrated hydrochloric acid at 120°C for 3 hours. Hepatic hydroxyproline contents were determined by the reaction of oxidized hydroxyproline with 4-(dimethylamino) benzaldehyde by a Colorimetric Kit (Cell Biolabs, San Diego, CA).
RNA Isolation and quantitative real-time PCR
Total RNA was isolated with Trizol Reagent (Invitrogen, Carlsbad, CA). Reverse transcription reactions and real time PCR were performed as described previously (29 
Quantification of tissue and plasma Lipids
Liver tissues were homogenized, and lipids were extracted in a mixture of chloroform and methanol (2:1), dried, and dissolved in 5% Triton X-100 in isopropanol. Hepatic and plasma triglyceride and cholesterol levels were then quantified using Infinity reagents from Thermo Scientific (Waltham, MA). Hepatic total free cholesterol was quantified using a kit from BioVision (Milpitas, CA). Hepatic and plasma free fatty acid was quantified using a kit from Wako Pure Chemical Industries, Ltd (Osaka, Japan).
Thiobarbituric acid reactive substances (TBARS), superoxide dismutase (SOD) and terminal deoxynucleotidyl transferase dUTP Nick End Labeling (TUNEL) assay
Liver tissues were homogenized and hepatic malondialdehyde (MDA) and SOD levels were determined by using a TBARS Assay Kit and Superoxide Dismutase Assay Kit, respectively (Cayman Chemical, Ann Arbor, MI). TUNEL Assay Kit was used to assay apoptotic cells in liver tissues (R&D, Minneapolis, MN).
Statistical Analysis
All experimental data are presented as mean  standard error (S.E. 
Results

Adenovirus-mediated expression of CYP7A1 ameliorated LPS-induced hepatic inflammation
Adenovirus-mediated Cyp7a1 gene transduction (Ad-Cyp7a1) has been used to increase CYP7A1 activity and bile acid synthesis in rat primary hepatocytes (30) . We used Ad-Cyp7a1 to overexpress Cyp7a1 in mice. Figure 1A shows that Ad-Cyp7a1 increased hepatic CYP7A1 mRNA levels by 12-fold compared to Ad-null mice, but did not affect CYP8B1, CYP27A1 and CYP7B1 mRNA levels. The mRNA levels of a FXR target gene in the liver, small heterodimer partner (SHP) and intestine FXR target genes SHP and fibroblast growth factor 15 (FGF15) were increased in Ad-Cyp7a1 mice compared to Ad-null mice ( Figure 1A ). The tissue bile acid contents increased significantly in the small intestine and gallbladder but not in the liver of Ad-Cyp7a1 mice ( Figure   1B ). The total bile acid pool increased two-fold in Ad-Cyp7a1 mice compared to Ad-null mice.
Analysis of gallbladder bile acids shows that TCA content was reduced and TMCAs increased in Ad-Cyp7a1 mice compared to Ad-null mice indicating stimulation of the alternative bile acid synthesis pathway to change bile acid composition (Supplemental Figure S1 ).
Adenovirus-mediated expression of Cyp7a1 ameliorated LPS-induced hepatic inflammation via FXR, but not TGR5
To study the roles of bile acid-activated receptors FXR and TGR5 in hepatic inflammation, Figure S5A) . It is surprised to notice that the total bile acid pool size in Ad null Fxr -/-mice was not significantly increased compared to Ad-null wild type mice. QPCR analysis shows that in Fxr -/-mice, Cyp7a1 and Cyp8b1 mRNA levels were increased but Cyp27a1, Cyp7b1 and Shp mRNA levels were reduced (Supplemental Figure S5B) indicating that bile acid synthesis via the classic pathway may be increased, but bile acid synthesis via the alternative pathway may be reduced and results in no significant change in bile acid pool
Real-time PCR analysis and ELISA assay showed that Ad-Cyp7a1 did not significantly affect LPS-induced pro-inflammatory cytokine and chemokine mRNAs ( Figure 2E ) and serum cytokine levels ( Figure 2F ) in Fxr -/-mice compared to Ad-null mice. However, Ad-Cyp7a1 ameliorated LPS-induced hepatic cytokine and chemokine mRNAs ( Figure 2G ) and serum cytokine levels ( Figure 2H ) in Tgr5 -/-mice compared to Ad-null mice. These data indicate that activation of FXR, but not TGR5, ameliorate LPS-induced hepatic inflammation.
Activation of FXR inhibited NF-ĸB activity
To further study the role of FXR in anti-inflammation, we used NF-κB/luciferase reporter assay to test if activation of FXR reduces NF-κB/luciferase reporter activity. The NF-κB-Luciferase reporter contains a canonical NF-κB response sequence. Figure 3A shows that both FXR selective agonists GW4064 (1μM) and OCA (10 μM) reduced the TNFα activated NF-κB reporter activity, and co-transfection with a FXR expression plasmid exacerbated the inhibitory effect of FXR agonists on the NF-κB reporter activity. Furthermore, GW4064 or OCA also inhibited the NF-κB reporter activity stimulated by p65, a component of the NF-κB complex ( Figure 3B ). In addition, activation of FXR by GW4064 or OCA inhibited LPS-induced pro-inflammatory cytokine mRNA expression in human primary hepatocytes ( Figure 3C ). These results demonstrated that activation of FXR inhibited NF-κB activity and pro-inflammatory cytokine production in hepatocytes.
Ad-Cyp7a1 inhibited NF-ĸB binding to cytokine gene promoters via a ligand-dependent interaction between FXR and p65 and steroid receptor coactivator-1 (SRC-1)
To further investigate the mechanisms of CYP7A1 and FXR in anti-inflammation in hepatocytes, we performed ChIP assay to evaluate the effect of CYP7A1 on NF-kB binding to the Tnf-α and Il-1β gene promoters, which contain the NF-κB binding sites. Liver lysates were isolated from mice treated with LPS for ChIP assay. An antibody against p65 was used to immunoprecipitate chromatin, and DNA fragments were PCR amplified with the primers designed to probe the NF-κB binding sites on the Tnf-α and Il-1β gene promoters. Figure 4A shows that p65 occupancy on the TNFα and IL-1β gene promoters was enhanced by LPS (Ad-null +LPS),
and that Ad-Cyp7a1 significantly reduced p65 occupancy on the TNF-α and IL-1β gene promoters (Ad-Cyp7a1+LPS). An antibody against FXR was used for ChIP assay and showed that FXR did not bind to the NF-κB binding sites on the Tnf-α and Il-1β promoters under the same treatment.
Next, we studied whether activation of FXR affects p65 binding to the Tnf-α and Il-1β gene promoters. Figure 4B shows that OCA had a similar effect as Ad-Cyp7a1 treatment to significantly inhibit p65 binding to the Tnf-α and Il-1β gene promoters. These data suggest that activation of FXR by bile acids and FXR agonist blocked p65 binding to the Tnf-α and Il-1β gene promoters.
We then performed mammalian two-hybrid assays to study whether FXR interacts with p65 to prevent p65 from binding to the NF-κB binding site as a mechanism for the antiinflammatory effects of FXR. In mammalian two-hybrid assay, a VP16-p65 fusion protein plasmid was co-transfected with GAL4-FXR fusion plasmids to stimulate GAL4-Luc reporter activity. As shown in Figure 4C , 
Lack of Cyp7a1 aggravated MCD diet-induced liver steatosis and fibrosis
Hepatic inflammation plays a critical role in fibrosis progression. MCD diet induces steatohepatitis and fibrosis associated with elevated hepatic triglyceride and cholesterol contents (23) . We therefore used a MCD diet model to study the role of Cyp7a1 in hepatic inflammation and steatosis and fibrosis. After feeding MCD diet for three weeks, both WT and Cyp7a1 -/-mice had significantly reduced body weights, but increased liver weight, hepatic steatosis, and serum AST and ALT levels more in Cyp7a1 -/-mice than wild type mice ( Figure 5A ). MCD diet feeding increased hepatic inflammation indicated by H&E staining ( Figure 5B ), and increased collagen fibers by Sirius Red ( Figure 5C ), Masson's Trichrome ( Figure 5D ) and α-smooth muscle actin (α-SMA) staining ( Figure 5E ) more in Cyp7a1 -/-mice than in WT mice. MCD diet also increased hydroxyproline collagen content more in Cyp7a1 -/-mice than in WT mice. However, MCD diet feeding significantly reduced plasma cholesterol, triglycerides and free fatty acids content in both wild type and Cyp7a1 -/-mice (Supplemental Figure S6A) . Oil-Red-O staining of neutral lipids further confirmed that chow-diet fed Cyp7a1 -/-mice had more hepatic steatosis than wild type mice, and MCD diet feeding increased hepatic steatosis more in Cyp7a1 -/-mice than in wild type mice (Supplemental Figure S6B ). These data suggested that lack of Cyp7a1 aggravated MCD dietinduced hepatic inflammation and fibrosis in mouse liver. Figure 6A shows that only hepatic triglycerides were higher in chow diet-fed Cyp7a1 -/-mice than wild type mice, but MCD diet significantly increased hepatic cholesterol, triglyceride and free fatty acid contents more in Cyp7a1 -/-mice than in wild type mice. Moreover, MCD diet did not affect total bile acid pool size in either wild type or Cyp7a1 -/-mice, the latter of which have a bile acid pool size about 60% of WT mice due to decreased bile acid contents in the liver, gallbladder and intestine ( Figure 6B ) as we reported previously (27) . MCD diet significantly increased inflammatory genes Tnf-α, Il1-β and C-X-C motif chemokine ligand 10 (Cxcl-10), and fibrosis genes transforming growth factor β (Tgfβ), tissue inhibitor of metalloproteinase (Timp1) and collagen-1α1, -1α2, -3α1 and -4α1 mRNA expression in Cyp7a1 -/-mice compared to WT mice ( Figure 6C ). Cyp8b1, Cyp27a1 and Cyp7b1 mRNA levels were significantly increased in Cyp7a1 -/-mice compared to WT mice ( Figure 6D ) (27) . The increase of Cyp8b1 mRNA may be due to reduced bile acid synthesis and pool size. Increased Cyp7b1 may increase bile acid synthesis via the alternative bile acid synthesis pathway to partially compensate for reduced bile acid synthesis via the classic pathway (27) . MCD diet strongly reduced Cyp8b1, Cyp7b1 and Cyp27a1 mRNA levels in Cyp7a1 -/-mice ( Figure 6D ), consistent with changing bile acid composition to that of wild type mice (Supplemental Figure S7) It is also possible that increased hepatic cytokines may decrease Abcg5/g8 expression (37).
MCD diet increased free cholesterol, oxidative stress and apoptosis, and aggravated hepatic fibrosis in Cyp7a1 -/-mice
It has been reported that free cholesterol increases oxidative stress and aggravates liver fibrosis (24) . We thus determined free cholesterol content in the liver of Cyp7a1 -/-mice. Figure 7A shows that hepatic free cholesterol levels increased in MCD diet-fed Cyp7a1 -/-mice compared to wild type mice. In addition, Filipin staining of free cholesterol in liver tissue further confirmed increased free cholesterol in MCD diet-fed Cyp7a1 -/-mice compared to wild type mice ( Figure 7B ).
TBARS (thiobarbituric acid reactive substance) assay of malondialdehyde, a product of oxidative stress, was significantly increased in MCD diet-fed Cyp7a1 -/-mice compared to WT mice.
Superoxide dismutase (SOD), the key enzyme for reducing reactive oxygen species, was much lower in MCD diet-fed Cyp7a1 -/-mice than wild type mice ( Figure 7C ). Further, TUNEL assay for apoptosis revealed that the numbers of cell death were markedly increased in MCD diet-fed
Cyp7a1
-/-mice compared to wild type mice ( Figure 7D ). Immunoblot analysis showed significant decrease of anti-apoptotic B cell lymphoma-2 (Bcl-2), and increase of apoptotic Bcl2-associated X protein (Bax) and cleaved-caspase 3 protein (CC3) in liver lysates of MCD diet-fed Cyp7a1 -/-mice than wild type mice ( Figure 7E ). These data suggest that lack of Cyp7a1 increases hepatic free cholesterol, which induces oxidative stress and apoptosis in hepatocytes and aggravates hepatic fibrosis in MCD diet-fed Cyp7a1 -/-mice.
Ad-Cyp7a1 reversed MCD diet-induced hepatic steatosis and fibrosis in Cyp7a1 -/-mice.
In previous studies, we found that transgenic expression of CYP7A1 in the liver prevents high-fat diet-induced obesity and insulin resistance in mice and ameliorated LPS-induced hepatic inflammation (26) . We further investigated if overexpression of Cyp7a1 could reverse hepatic steatosis and fibrosis in MCD diet-fed Cyp7a1 -/-mice. Cyp7a1 -/-mice were fed with MCD diet for 3 weeks. On week 2, mice were injected with 1x10 9 pfu per mouse of either Ad-null (control) or
Ad-Cyp7a1 and were sacrificed one week later. Figure 8A shows that Ad-Cyp7a1 reduced MCD Figure 8C ). Furthermore, Ad-Cyp7a1 reduced MCD diet-induced hepatic free cholesterol content, TBARS level and apoptosis ( Figure 8D ). In addition, it was found that Ad-Cyp7a1 reduced total hepatic cholesterol and triglyceride contents but not free fatty acid levels in Cyp7a1 -/-mice (Supplemental Figure S8 ). These data suggested that overexpression of Cyp7a1 prevented MCD-diet-induced NASH in Cyp7a1 -/-mice.
Discussion
In this study, we used gain-of-function and loss-of-function mouse models to investigate the roles of Cyp7a1, FXR and TGR5 in hepatic steatosis, inflammation and fibrosis. Results from this study suggest that overexpression of Cyp7a1 ameliorated LPS-induced inflammatory cell infiltration and pro-inflammatory cytokine production, and FXR but not TGR5 mediates the antiinflammatory function of bile acids in hepatocytes. Conversely, genetic ablation of the Cyp7a1 gene exacerbated MCD diet-induced hepatic steatosis and fibrosis in mice likely caused by accumulation of free cholesterol, which increases oxidative stress and aggravates hepatic fibrosis and apoptosis. It has been reported recently that a high-cholesterol diet exacerbates liver fibrosis in mice and free cholesterol is accumulated in hepatic stellate cells (23, 24) and Kupffer cells, (25) and accelerates liver fibrosis and NASH progression. Increasing free cholesterol accelerated oxidative stress via up-regulation of the enzymes involved in the generation of ROS and the downregulation of antioxidant enzymes (38) . The mitochondrial overloading of free cholesterol, but not triglycerides and free fatty acids, decreases mitochondrial glutathione and sensitizes it to the TNF-α-mediated apoptosis of hepatocytes (39) . The accumulation of lipids in the cytoplasm of hepatocytes is considered the first step in the development of liver fibrosis. Interestingly, we also found that triglyceride and free fatty acid levels were higher in Cyp7a1 -/-mice than WT mice fed with MCD diet. On the other hand, overexpression of Cyp7a1 stimulates bile acid synthesis to reduce hepatic free cholesterol and hepatic inflammation.
Our current study suggests a mechanism in which ligand-activated FXR directly interacts with p65 and blocks p65 from binding to the NF-κB binding sites on the cytokine promoters or competes for co-activator SRC-1 and results in inhibiting cytokine production in hepatocytes. A previous study reports that sumoylation of FXR stimulates FXR interaction with p65 to recruit corepressors to inhibit NF-κB-activated pro-inflammatory cytokine production (40) . Another study reports that TGR5 antagonizes NF-κB activity to regulate inflammatory response in hepatocytes (15) , but TGR5 induced Il1-β and Tnfα expression in Kupffer cells (16) . Our finding that LPS stimulates inflammatory cytokine production in Tgr5 -/-mice and overexpression of CYP7A1 in wild type or Tgr5 -/-mice reduces LPS-induced pro-inflammatory cytokine production suggesting that TGR5 signaling may not play a major role in anti-inflammation in the liver.
Bile acid synthesis plays a critical role in maintaining hepatic cholesterol homeostasis, which is maintained by the balance of uptake of dietary cholesterol and de novo cholesterol synthesis, and catabolism of cholesterol to bile acids, biliary cholesterol secretion, and steroid hormone synthesis.
It should be noted that bile acid synthesis accounts for catabolism of about 50% cholesterol and disposal of 45% cholesterol as acidic steroids (41) . Thus bile acid synthesis plays a major role in maintaining whole body cholesterol homeostasis. Stimulating CYP7A1 activity and bile acid synthesis is known to activate liver FXR signaling and intestine TGR5 signaling to reduce hepatic inflammation, increase insulin sensitivity, improve glycemic control and improve obesity (7, 11, 42) , however, the underlying mechanism is not completely understood (42, 43) . In Cyp7a1 transgenic mice, bile acid pool size is doubled but TCA content is markedly reduced and these mice are resistant to Western diet-induced obesity and diabetes (26) . Cholic acid is most efficacious among all bile acids in absorption of dietary cholesterol and fats, and has been linked to obesity and diabetes in human patients (44) . We reported recently that Cyp7a1 -/-mice, with a smaller bile acid pool and lower TCA, have improved glucose and insulin tolerance (27) .
Interestingly, dietary supplementation of cholic acid to Cyp7a1 -/-mice reverses glucose and insulin tolerance phenotypes. This current study also suggests that increased cholic acid content in bile acid pool of MCD diet treated Cyp7a1 -/-mice may increase dietary fat and cholesterol absorption and contributes to increased hepatic cholesterol and oxidative stress and hepatic fibrosis.
Importantly, this study shows that overexpression of Cyp7a1 in MCD diet-fed Cyp7a1 -/-mice could reduce hepatic free cholesterol and reverse the hepatic steatosis, inflammation and fibrosis further proofs our hypothesis that Cyp7a1 plays a critical role in protection the liver from inflammation and fibrosis by maintaining cholesterol homeostasis.
In summary, our current study suggests that increased Cyp7a1 expression and bile acid synthesis ameliorated hepatic inflammation through activation of FXR, whereas reduced bile acid synthesis in Cyp7a1 -/-mice aggravated MCD diet-induced hepatic inflammation and fibrosis.
Maintaining bile acid and cholesterol homeostasis is important for protecting liver from injury and non-alcoholic fatty liver disease.
by guest, on August 15, 2017 www.jlr.org GW4064 (1 µM) or OCA (10 µM) in the absence or presence of LPS (100 ng/ml) for 6 h. Total RNA was isolated and mRNA levels of inflammatory genes were determined by qPCR. Free cholesterol contents in the liver were detected using a Cholesterol Assay Kit. 
